United States · 
Who invested in Avilar Therapeutics?
Avilar Therapeutics's investors include RA Capital Management, Sanofi and Astella.
United States · Seed startup
Who invested in Avilar Therapeutics
Funding summaryUpdated 26 Oct 2026
$15Mraised across 1 round since 2023, from 1 source
- Latest round
- Seed, $15MFeb 2023
- Investors
- 3
The rounds
- Feb 2023
Founders and team
From the SEC filings it signed: 5 on the team.
- Adam MuzikantExecutive Officeri
- Daniel GrauExecutive Officer, Directori
- David NeafusExecutive Officeri
- Phil GrahamExecutive Officeri
- Stephanie TozzoExecutive Officeri
On the board, as filediJoshua ResnickMartin FreedMilind DeshpandePaulina HillTheresa Cameron
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Avilar Therapeutics
How much has Avilar Therapeutics raised?
Avilar Therapeutics has raised $15M across 1 round since 2023.
When did Avilar Therapeutics last raise?
Avilar Therapeutics's most recent round was a Seed of $15M in Feb 2023.
What was Avilar Therapeutics's biggest round?
Its most recent round, $15M in Feb 2023, is also its largest on record.
Who backed Avilar Therapeutics first?
Avilar Therapeutics's first round on record, in Feb 2023, was backed by RA Capital Management, Sanofi and Astella.
What stage is Avilar Therapeutics at?
Avilar Therapeutics's latest named round is a Seed, in Feb 2023.
Where is Avilar Therapeutics based?
Avilar Therapeutics is based in the United States.
Companies like Avilar Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.